What does the federal law actually say?
Growth hormone has its own criminal statute, which is unusual for a medicine. Under 21 U.S.C. 333(e), anyone who knowingly distributes human growth hormone, or possesses it with intent to distribute, for any use in humans other than a disease or recognized medical condition that the FDA has authorized, and on the order of a physician, commits an offense punishable by up to five years in prison.
A few more details from the statute:
- If the offense involves someone under 18, the maximum rises to 10 years.
- “Human growth hormone” means somatropin, somatrem or an analogue of either.
- The Drug Enforcement Administration is authorized to investigate.
For most medicines, using an approved drug for an unapproved purpose is a normal part of medical practice. This statute removes that flexibility for growth hormone, which is why “anti-aging HGH” is a legal problem and not just a medical debate.
What are the approved uses for growth hormone in adults?
They are narrow. The Genotropin (somatropin) label lists adult use for growth hormone deficiency, whether it began in childhood or adulthood. Getting that diagnosis takes more than a low lab number: the Endocrine Society guideline on adult growth hormone deficiency says confirmation usually requires a stimulation test, unless there is a proven genetic or structural cause from childhood.
The gradual drop in growth hormone that comes with age is a different thing. Our page on growth hormone decline in men explains how the two are told apart, and the IGF-1 blood test page covers the marker most men see first.
How are sermorelin and tesamorelin different from HGH?
They do not contain growth hormone. Both are versions of growth hormone releasing hormone (GHRH), the signal your hypothalamus sends to the pituitary. They prompt the pituitary to release its own growth hormone in pulses, and your body’s feedback system still decides how much comes out.
| HGH (somatropin) | Sermorelin | Tesamorelin | |
|---|---|---|---|
| What it is | Growth hormone itself | First 29 amino acids of GHRH | Stabilized GHRH analogue |
| How it works | Replaces the hormone directly | Prompts your pituitary’s own release | Prompts your pituitary’s own release |
| FDA status | Approved for specific deficiency conditions | Formerly approved as Geref; now compounded | Approved (Egrifta) for HIV-associated abdominal fat |
| Use for aging or body composition | Not an authorized use | Off-label | Off-label |
Geref, the original sermorelin product, was withdrawn from sale, and in 2013 the FDA determined that it was not withdrawn for reasons of safety or effectiveness. Tesamorelin is a biologic and is supplied as the FDA-approved product, not compounded. Our tesamorelin page covers its use for visceral fat.
Do they deliver an anti-aging effect?
Expect modest, measurable changes rather than a reversal of aging. In a 16-week study of a sermorelin-type GHRH peptide in men and women aged 55 to 71, nightly injections raised growth hormone and IGF-1, increased skin thickness, and increased lean body mass in the men. Sleep quality did not change, and there was a temporary rise in blood fats that resolved.
That is a useful but limited result, and it came from a small study. No peptide has been shown to extend life or turn back the clock, and any claim that one does goes beyond the evidence.
Related question: what about other growth hormone peptides?
CJC-1295 and ipamorelin are often sold as HGH alternatives online. Our page asking whether CJC-1295 and ipamorelin are legal explains why they are not on our menu. For the full legal history, read our article on HGH, anti-aging and federal law.
How Ultimate Male handles growth hormone requests
If you came looking for HGH, the conversation starts with what you want to change: recovery, body fat, energy or sleep. Labs at our San Gabriel or Downey clinic show your IGF-1 and the other markers that often explain those symptoms, including testosterone and thyroid.
If a growth hormone pathway makes sense, your provider explains sermorelin or tesamorelin, what each can realistically do, and how IGF-1 is monitored on follow-up labs. The visit is there to evaluate you, and it does not commit you, or the provider, to any treatment.
